                Figure 7.  Loss of p21 rescues functional BM-derived tumor angiogenesis in Id1-/- mice.A) Flow cytometric analysis of the EPC fraction of BM cells from wild type; Id1-/-; Id1-/- p21-/- and p21-/- mice. The plots represent the percentage of cKit+ Flk-1+ cells in the population of Lin- BM cells in the indicated groups of mice. Average±SEM : wt = 0.25±0.03 (n = 8); Id1-/- = 0.054±0.009 (n = 6); Id1-/- p21-/- = 0.2±0.018 (n = 7); p21-/- = 0.17±0.02 (n = 7). p = 0.0007 ***, p = 0.0012 ** B) Flow cytometry analysis of the circulating EPC fraction in the peripheral blood of wt; Id1-/-; Id1-/- p21-/- and p21-/- mice. The plots represent the number of CD45-cKit+ Flk-1+ CD13+ cells per µl of blood in the different groups of mice. Average±SEM: wt = 0.31±0.04 (n = 8); Id1-/- = 0.024±0.01 (n = 8); Id1-/- p21-/- = 0.38±0.042 (n = 6); p21-/- = 0.35±0.09 (n = 3). p&lt;0.001 *** C) Growth curve of LLC tumors implanted into wild type; Id1-/-; Id1-/- p21-/- and p21-/- mice. D) VE-cadherin immunofluorescence on tumor sections showing the vascular density in the indicated genotypes. Scale bar 100 µm.

